Skip to main content
Log in

Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets

  • Cornea
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

When ophthalmic drug solutions are developed and clinically applied, their influence on corneal epithelium is an important issue. In the past, cells obtained by monolayer culture in vitro were used for evaluation of such influence. We recently created an experimental model of cell damage repair closer to the live body than conventional models by using layered sheets of cultured corneal epithelium. The present study was undertaken to evaluate the influence of ophthalmic moxifloxacin hydrochloride (MFLX) solution in comparison to that of ophthalmic levofloxacin (LVFX) solution using this model.

Methods

Corneal epithelium cells were collected from corneal tissue specimens of white rabbits and subjected to air-lift culture to induce layering. Epithelial cell defects were created by a sponge soaked in 1 N aqueous sodium hydroxide. After removal of the sponge, either ophthalmic MFLX solution or ophthalmic LVFX solution was dropped onto the specimens three times daily (washed 1 min after each dose, followed by continuation of air-lifting culture). The percentage of the defective area repaired (percent defect repair) was evaluated. Each of the ophthalmic MFLX solution and the ophthalmic LVFX solution was used after the stock solution was diluted fourfold (1:4). Drug-free culture medium served as the negative control. Benzalconium chloride solution (BAC) 0.01% served as the positive control.

Results

In the negative control group, complete repair of the defect with epithelial cells was seen 4 days after the start of treatment. In the positive control group, repair was suppressed. In the MFLX group and the LVFX group, the defect was repaired at each drug concentration, showing no significant difference from the negative control group. Thus, in this study using layered sheets of cultured corneal epithelium (a model closer to the living body than conventional models), the corneal epithelial defect was repaired in the ophthalmic MFLX solution treatment group and the ophthalmic LVFX solution treatment group to a degree similar to that in the negative control group.

Conclusions

These results suggest that neither MLFX nor LVFX suppresses repair of corneal epithelial damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Thompson AM (2007) Ocular toxicity of fluoroquinolones. Clin Experiment Ophthalmol 35:566–577

    Article  PubMed  Google Scholar 

  2. Mallari PL, McCarty DJ, Daniell M, Taylor H (2001) Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol 131:131–133

    Article  PubMed  CAS  Google Scholar 

  3. Konishi M, Yamada M, Mashima Y (1998) Corneal ulcer associated with deposits of norfloxacin. Am J Ophthalmol 125:258–260

    Article  PubMed  CAS  Google Scholar 

  4. Castro-Munozledo F (2008) Corneal epithelial cell cultures as a tool for research, drug screening and testing. Exp Eye Res 86:459–469

    Article  PubMed  CAS  Google Scholar 

  5. Ly LT, Cavanagh HD, Petroll WM (2006) Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea. Eye Contact Lens 32:161–165

    Article  PubMed  Google Scholar 

  6. Scuderi AC, Paladino GM, Marino C, Trombetta F (2003) In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells. Cornea 22:468–472

    Article  PubMed  Google Scholar 

  7. Sakurai H, Era T, Jakt LM, Okada M, Nakai S, Nishikawa S (2006) In vitro modeling of paraxial and lateral mesoderm differentiation reveals early reversibility. Stem Cells 24:575–586

    Article  PubMed  CAS  Google Scholar 

  8. Marino C, Paladino GM, Scuderi AC, Trombetta F, Mugridge K, Enea V (2005) In vivo toxicity of netilmicin and ofloxacin on intact and mechanically damaged eyes of rabbit. Cornea 24:710–716

    Article  PubMed  Google Scholar 

  9. Kim SY, Lim JA, Choi JS, Choi EC, Joo CK (2007) Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro. Cornea 26:720–725

    Article  PubMed  Google Scholar 

  10. Koizumi N, Fullwood NJ, Bairaktaris G, Inatomi T, Kinoshita S, Quantock AJ (2000) Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci 41:2506–2513

    PubMed  CAS  Google Scholar 

  11. Burgalassi S, Chetoni P, Monti D, Saettone MF (2001) Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. Toxicol Lett 122:1–8

    Article  PubMed  CAS  Google Scholar 

  12. Huhtala A, Nurmi SK, Tahti H, Salminen L, Alajuuma P, Rantala I, Helin H, Uusitalo H (2003) The immunohistochemical characterisation of an SV40-immortalised human corneal epithelial cell line. Altern Lab Anim 31:409–417

    PubMed  CAS  Google Scholar 

  13. Hariprasad SM, Shah GK, Chi J, Prince RA (2005) Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. J Cataract Refract Surg 31:2142–2146

    Article  PubMed  Google Scholar 

  14. Donaldson KE, Marangon FB, Schatz L, Venkatraman AS, Alfonso EC (2006) The effect of moxifloxacin on the normal human cornea. Curr Med Res Opin 22:2073–2080

    Article  PubMed  CAS  Google Scholar 

  15. Matsumoto K, Ohashi Y, Usui M, Miyanaga Y, Kitano S (2007) Phase III study of moxifloxacin ophthalmic solution in bacterial corneal infections (corneal epithelial inflammation, corneal ulcer). Stem Cells 24:575–586

    Google Scholar 

  16. Koizumi N, Kinoshita S (2003) Ocular surface reconstruction, amniotic membrane, and cultivated epithelial cells from the limbus. Br J Ophthalmol 87:1437–1439

    Article  PubMed  CAS  Google Scholar 

  17. Liu J, Song G, Wang Z, Huang B, Gao Q, Liu B, Xu Y, Liang X, Ma P, Gao N, Ge J (2007) Establishment of a corneal epithelial cell line spontaneously derived from human limbal cells. Exp Eye Res 84:599–609

    Article  PubMed  CAS  Google Scholar 

  18. Sladowski D, Combes R, van der Valk J, Nawrot I, Gut G (2005) ESTIV questionnaire on the acquisition and use of primary human cells and tissue in toxicology. Toxicol In Vitro 19:1009–1013

    Article  PubMed  CAS  Google Scholar 

  19. Cha SH, Lee JS, Oum BS, Kim CD (2004) Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin Experiment Ophthalmol 32:180–184

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norihiko Ito.

Additional information

The authors have no proprietary interests in this study. The authors have full control of all primary data and they agree to allow Graefes Archive for Clinical and Experimental Ophthalmology to review their data upon request.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyake, T., Ito, N., Tajima, K. et al. Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets. Graefes Arch Clin Exp Ophthalmol 250, 1035–1041 (2012). https://doi.org/10.1007/s00417-011-1916-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-011-1916-1

Keywords

Navigation